Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Clinical trial NCT01956669 · COMPLETED
Trial details
- NCT number
- NCT01956669
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-08
- Primary completion
- 2019-11-05
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.